—

Stryker Corporation (SYK) — Technical state

As of 2026-11-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 50 out of 100 (momentum 49 · quality 66 · valuation 35), as of 2026-11-11.
  • Signal: Stochastic turned down — Its stochastic crossed down from overbought (%K 69.4 under %D 79.2) 2 sessions ago — momentum is cooling. (as of 2026-11-09)
  • Trend: Stryker Corporation trades 11.5% above its 50-day and 1.0% above its 200-day moving average. (as of 2026-11-09)
  • Index seat: HALO Growth 100

Stryker Corporation makes medical technology sold to hospitals and clinics, organised into two areas. MedSurg and Neurotechnology covers surgical tools, patient-safety systems, navigation equipment, endoscopy, emergency and intensive-care products, and devices for treating stroke.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the SYK overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Stochastic turned down

Its stochastic crossed down from overbought (%K 69.4 under %D 79.2) 2 sessions ago — momentum is cooling.

The moving-average stack

FAQ · from the current data · as of 2026-11-09

Quick answers

What is the current Closelooknet signal on SYK?

Stochastic turned down — Its stochastic crossed down from overbought (%K 69.4 under %D 79.2) 2 sessions ago — momentum is cooling. As of 2026-11-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is SYK above its 50-day and 200-day moving averages?

As of 2026-11-09, Stryker Corporation trades +11.5% above its 50-day and +1% above its 200-day average, with the 20-day +6.4% away.

How far is SYK from its 52-week high?

16.6% below the 52-week high and 22% above the 52-week low, as of 2026-11-09.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.